FHLCvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with FHLC, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
FHLC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/26/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FHLC ETF 2 | +3.76%– | +8.83%– | +16.94%– | +23.63%– | +53.42%– | +39.86%– |
| Flows | FHLC ETF 2 | +$77M– | +$226M– | +$478M– | +$542M– | -$184M– | +$18M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FHLC ETF 2 | +17.04%– | +15.91%– | +14.92%– | +15.51%– |
| Max drawdown | FHLC ETF 2 | -5.64%– | -10.35%– | -16.88%– | -17.78%– |
| Max drawdown duration | FHLC ETF 2 | 56d– | 169d– | 435d– | 762d– |
Trading data
FHLC | ETF 2 | |
Last sale 10/27/2026 at 1:30 PM | $86.08 | – |
| Previous close 10/26/2026 | $86.00 | – |
| Consolidated volume 10/26/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
FHLC | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/27/2026 at 1:30 PM
Live
Closed
FHLC | ETF 2 | |
|---|---|---|
| Last price | $86.08 | – |
| 1D performance | +0.09% | – |
| AuM | $3.82 B | – |
| E/R | 0.084% | – |
Characteristics
FHLC | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | Fidelity | – |
| Benchmark | MSCI USA IMI Health Care 25/50 Index | – |
| N° of holdings | 338 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 21, 2013 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
FHLC
USA
97.14%
Other
2.86%
ETF 2
Sectors
FHLC
Healthcare
98.23%
Other
1.77%
ETF 2
Advertisement
Diversification
FHLC
Total weight of top 15 holdings out of 15
60.85%
ETF 2
–
Top 15 holdings
Data as of August 31, 2026
FHLC
Eli Lilly & Co.
12.94%
Johnson & Johnson
8.88%
AbbVie, Inc.
6.21%
Merck & Co., Inc.
5.04%
UnitedHealth Group, Inc.
4.91%
Amgen, Inc.
3.21%
Thermo Fisher Scientific, Inc.
3.19%
Abbott Laboratories
2.69%
Gilead Sciences, Inc.
2.49%
Pfizer Inc.
2.19%
Vertex Pharmaceuticals, Inc.
1.90%
Danaher Corp.
1.89%
Bristol Myers Squibb Co.
1.87%
Intuitive Surgical, Inc.
1.82%
CVS Health Corp.
1.63%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
